By Frank Prenesti
Date: Tuesday 11 Oct 2022
(Sharecast News) - Shares in healthcare company PureTech fell on Tuesday as the company said it and US-based Nektar Therapeutics had ended merger talks only four days after they announced a potential tie up.
By Michele Maatouk
Date: Friday 07 Oct 2022
(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.
By Michele Maatouk
Date: Friday 07 Oct 2022
(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.
No recent information was found.
Currency | US Dollars |
Share Price | $ 57.77 |
Change Today | $ 2.81 |
% Change | 5.11 % |
52 Week High | $63.92 |
52 Week Low | $7.36 |
Volume | 2,293,078 |
Shares Issued | 180.09m |
Market Cap | $10,404m |
RiskGrade | 333 |
Strong Buy | 3 |
Buy | 3 |
Neutral | 1 |
Sell | 1 |
Strong Sell | 0 |
Total | 8 |
Time | Volume / Share Price |
15:59 | 100 @ $57.72 |
15:59 | 100 @ $57.72 |
15:59 | 400 @ $57.71 |
15:59 | 100 @ $57.71 |
15:59 | 100 @ $57.71 |
You are here: research